Michael M. Barnes
Friday, December 30, 2016
Costly Drug for Fatal Muscular Disease Wins F.D.A. Approval
Spinraza, a “life-changing” drug for spinal muscular atrophy, will cost as much as $750,000 for the first year of treatment and $375,000 annually after that.
from Well http://ift.tt/2iO1USd
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment